ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.
Exploring the companies and themes that make up this emerging and exciting new sector
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines
MindMed launches its digital medical division.
ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round
With ATAI eying a Spring 2021 IPO, it announces a $125 million private equity financing for Series C.
PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform
Revive Therapeutics and PharmaTher are teaming up to research the potential of psilocybin as a cancer treatment.
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
Field Trip announces a new clinics-based research program, beginning with psychedelic therapies for military veterans.
Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering
Including its new financing, Mind Cure currently has in excess of CAD$5 million in cash.
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
Numinus plans a "compassionate access" clinical trial of psilocybin to treat substance abuse.
Psychedelic Drug Therapy: Cure Your Mind, Save Your Heart?
Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?
Delic Corp Commences Trading On CSE
Delic Corp is a Delaware-based psychedelics company that has gone public via RTO.
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program
Field Trip is entering the (already legal) Netherlands psilocybin market with a "Field Trip Health Center" in Amsterdam.
Mydecine Innovations Group Offers Management and Clinical Trials Update
Mydecine provides an update on its Phase 2A clinical trial of psilocybin-assisted psychotherapy for the treatment of PTSD.
Mind Cure Science Advisor Becomes First CSO As It Builds World-Class Team
Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.